Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F

Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing number D.24-0157 and its Form 20-F with the U.S. Securities and Exchange Commission (SEC). Valneva’s 2023 Universal Registration Document – available in its entirety in French – includes the Company’s 2023 Annual Fina

Related Keywords

France ,Saint Herblain ,Pays De La Loire ,French ,Joshua Drumm ,Alain Bombard ,French Financial Markets Authority ,Exchange Commission ,Pfizer ,Company Sustainability ,Company Annual Management ,Global Communications ,Euronext Paris ,Registration Document ,Financial Report ,Annual Management Report ,Director Corporate Governance Report ,Sustainability Report ,European Investor ,Global Investor Relations ,